Hisamitsu Pharmaceutical (Germany) Investor Sentiment

HPX Stock  EUR 26.60  1.00  3.62%   
Roughly 61% of Hisamitsu Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Hisamitsu Pharmaceutical Co suggests that many traders are alarmed regarding Hisamitsu Pharmaceutical's prospects. The current market sentiment, together with Hisamitsu Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Hisamitsu Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Hisamitsu Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Hisamitsu daily returns and investor perception about the current price of Hisamitsu Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
few days ago at news.google.com         
Institutions own 45 percent of Hisamitsu Pharmaceutical Co., Inc. shares but individual investors co...
Google News at Macroaxis
over a week ago at news.google.com         
Hisamitsu Pharmaceutical Co., Inc. Reports Consolidated and Non-Consolidated Earnings Results for th...
Google News at Macroaxis
over three weeks ago at news.google.com         
Hisamitsu Pharmaceuticals Dividend Will Be 45.00 - Simply Wall St
Google News at Macroaxis
over three weeks ago at news.google.com         
Hisamitsu Pharmaceutical Co. Reports Strong Q3 FY2025 Results with Increased Dividends - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Hisamitsu Pharmaceutical Is Due To Pay A Dividend Of 45.00 - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
Does Hisamitsu Pharmaceutical Co., Inc.s Weak Fundamentals Mean A Downturn In Its Stock Should Be Ex...
Google News at Macroaxis
over two months ago at news.google.com         
Hisamitsu Pharmaceutical Has Announced A Dividend Of 45.00 - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Hisamitsu Pharmaceutical Co. Reports Q2 Growth - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
Hisamitsu reveals 70 percent of Thai office workers often have back pain, sending Fetus Diclofenac t...
Google News at Macroaxis
over three months ago at news.google.com         
Hisamitsu Pharmaceutical Co., Inc. Not Lagging Market On Growth Or Pricing - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Why It Might Not Make Sense To Buy Hisamitsu Pharmaceutical Co., Inc. For Its Upcoming Dividend - Si...
Google News at Macroaxis
over three months ago at news.google.com         
Hisamitsu Pharmaceuticals Shareholders Will Receive A Bigger Dividend Than Last Year - Simply Wall S...
Google News at Macroaxis
over six months ago at news.google.com         
Hisamitsu Pharmaceutical Has Announced That It Will Be Increasing Its Dividend To 45.00 - Simply Wal...
Google News at Macroaxis
over six months ago at news.google.com         
Hisamitsu Pharmaceutical Has Announced That It Will Be Increasing Its Dividend To 45.00 - Simply Wal...
Google News at Macroaxis
over six months ago at news.google.com         
Hisamitsu Pharmaceutical First Quarter 2025 Earnings EPS Beats Expectations, Revenues Lag - Simply W...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Hisamitsu Pharmaceutical that are available to investors today. That information is available publicly through Hisamitsu media outlets and privately through word of mouth or via Hisamitsu internal channels. However, regardless of the origin, that massive amount of Hisamitsu data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hisamitsu Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hisamitsu Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hisamitsu Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hisamitsu Pharmaceutical alpha.

Hisamitsu Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Hisamitsu Stock analysis

When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
CEOs Directory
Screen CEOs from public companies around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges